Skip to main content

Progressive resolution optimizer (PRO) predominates over photon optimizer (PO) in sparing of spinal cord for spine SABR VMAT plans

Abstract

Background

we assessed the performance of the optimization algorithms by comparing volumetric modulated arc therapy generated by a progressive resolution optimized (VMATPRO) and photon optimizer (VMATPO) in terms of plan quality, MU reduction, sparing of the spinal cord (or cauda equina), and plan complexity.

Methods

Fifty-seven patients who received spine stereotactic ablative radiotherapy (SABR) with tumors located in the cervical, thoracic, and lumbar spine were retrospectively selected. For each patient, VMATPRO and VMATPO with two full arcs were generated with using the PRO and PO algorithms. For dosimetric evaluation, the dose-volumetric (DV) parameters of the planning target volume (PTV), organs at risk (OARs), the corresponding planning organs at risk (PRV), and 1.5-cm ring structure surrounding the PTV (Ring1.5 cm) were calculated for all VMAT plans. The total number of monitor units (MUs) and the modulation complexity score for the VMAT (MCSv) were compared. To investigate the correlations of OAR sparing to plan complexity, Pearson’s and Spearman’s correlation tests were conducted between the two algorithms (PO – PRO, denoted as Δ) in the DV parameters for normal tissues, total MUs, and MCSv.

Results

For the PTVs, Target conformity and dose homogeneity in the PTVs of VMATPRO were better than those of VMATPO with statistical significance. For the spinal cords (or cauda equine) and the corresponding PRVs, all of the DV parameters for VMATPRO were markedly lower than those for VMATPO, with statistical significance (all p < 0.0001). Among them, the difference in the maximum dose to the spinal cord between VMATPRO and VMATPO was remarkable (9.04 Gy vs. 11.08 Gy with p < 0.0001). For Ring1.5 cm, no significant difference in V115% for VMATPRO and VMATPO was observed.

Conclusions

The use of VMATPRO resulted in improved coverage and uniformity of dose to the PTV, as well as OARs sparing, compared with that of VMATPO for cervical, thoracic, and lumbar spine SABR. Better dosimetric plan quality generated by the PRO algorithm was observed to result in higher total MUs and plan complexity. Therefore, careful evaluation of its deliverability should be performed with caution during the routine use of the PRO algorithm.

Peer Review reports

Background

Bone metastases occur in approximately one-third of all patients with advanced malignant cancers, of which 70% originate within the spine [1,2,3,4]. Radiotherapy has been the standard treatment for decades for patients with spinal metastasis not requiring or amenable to surgery [5]. With the rapid development of technology and equipment, stereotactic ablative radiotherapy (SABR) can deliver a high dose in a few fractions (one–five fractions) with a steep dose fall-off, providing a high biologically equivalent dose to the target volume and sparing nearby normal organs adjacent to the target volume. Several studies have shown that SABR for spinal metastasis is more effective for local tumor control and pain relief than traditional radiotherapy [6,7,8,9,10].

Conversely, other studies reported that radiation myelopathy, the most morbid complication associated with spine SABR, has been observed [11, 12]. The risk of radiation myelopathy is low, but it can have a huge negative impact on the quality of life and prognosis. Symptoms can include difficulty walking, numbness, limb weakness, loss of bladder and bowel control, and death [11, 12]. Therefore, to prevent radiation myelopathy, it is important to reduce the dose to the spinal cord and cauda equina as much as possible. Thus, an extremely rapid dose fall-off between the spine and spinal cord should be achieved because the spinal cord is surrounded by irregular vertebral bodies and the target volumes for spinal metastasis are irregularly shaped.

In this regard, volumetric modulated arc therapy (VMAT) with varying gantry speeds, dose rates, and multi-leaf collimator (MLC) speeds is a suitable treatment option for spine SABR. These modulations of VMAT can generate steep dose gradients between target volumes and organs at risk (OARs) and provide highly conformal target coverage within a shorter treatment time, compared with the intensity modulated radiotherapy (IMRT) technique [13,14,15]. For the generation of VMAT plans, an inverse optimization process that determines the combination of field shapes and segment weights has been used based on dose-volume histogram (DVH) information. However, this method leaves little room for user intervention during the optimization process. Therefore, the dosimetric quality of the VMAT plans is highly dependent on the performance of optimization algorithms in the treatment planning system (TPS).

Recently, Varian Eclipse TPS (Varian Medical Systems, Palo Alto, CA, version 13.5) introduced a new optimization algorithm called the photon optimizer (PO). The PO algorithm can be used for both IMRT and VMAT plans, whereas the dose-volume optimizer (DVO) and progressive resolution optimizer (PRO) from the previous version of Eclipse were used for IMRT and VMAT plan generation, respectively. The main difference of the PRO algorithm from the PO algorithm is that the PO algorithm uses a new structure model, where the structure, DVH calculations, and dose sampling are defined spatially by using a single matrix over the image instead of a point cloud model that is used in PRO algorithm [16,17,18]. User-specified fixed values (1.25 mm, 2.5 mm, or 5 mm) are used for the voxel resolution of the matrix [16,17,18]. For fast dose estimation during optimization, both the PRO and PO algorithms utilize a multiresolution dose calculation algorithm that go through four multi-resolution levels, and include the intermediate dose calculation option to acquire better dosimetric plan quality [16, 18].

Several studies have analyzed the dosimetric impact, treatment efficiency, and plan complexity between various plans generated by the PRO and PO algorithms for various sites. Liu et al. demonstrated that the PO algorithm showed comparable plan quality and less plan complexity with fewer total monitor units (MUs) for VMAT planning of both lung SABR and brain stereotatic radiosurgery (SRS) [17]. Other institutions have also shown the superiority of the PO algorithm over the PRO algorithm in terms of treatment efficiency (MU reduction) without compromising the VMAT plan quality for lung SABR [18, 19]. However, some studies have reported contradictory results for the PO algorithm. Binny et al. investigated the plan quality of intensity-modulated arc therapy for the prostate, head and neck, and brain treatment sites [16]. They observed that plans optimized using the PO algorithm had higher MLC complexity and higher total MUs, while improving OAR sparing with a similar degree of dose conformity to the target volume, compared with those optimized using the PRO algorithm [16]. Kim et al. yielded conflicting results for IMRT and VMAT planning techniques [20]. Although prostate IMRT and VMAT plans generated using the PO algorithm showed an improvement in plan quality for the target volume over the DVO and PRO algorithms, total MU reductions for the PO algorithm were observed only in the IMRT plans, whereas more total MUs for the PO algorithm were used in the VMAT plans [20]. Therefore, the superiority of the PO algorithm is not obvious and varies based on the radiotherapy regimen used and the treatment site. To the best of our knowledge, no planning study of VMAT for spine SABR generated using the PRO and PO algorithms has been performed. In this study, we assessed the performance of the optimization algorithms by comparing PRO-generated VMAT plans (VMATPRO) with PO-generated VMAT plans (VMATPO) in terms of plan quality, MU reduction, sparing of the spinal cord (or cauda equina), and plan complexity. We included 57 patients who received spine SABR with tumors located in the cervical, thoracic, and lumbar spine.

Methods

Patient selection, simulation, and contouring

From January 2016 to September 2020, 57 patients with spinal metastasis who had a single target volume were retrospectively chosen at our institution. Twenty-eight patients with cervical or thoracic spinal metastases and 29 patients with lumbar spinal metastasis were selected. All patients were previously treated with SABR using the VMAT technique. Approval for this study was obtained from the Institutional Review Board (IRB No. 2020-11-008). All patients underwent computed tomography (CT) scans using various immobilization techniques at the treatment sites using the Brilliance CT Big Bore™ (Philips, Amsterdam, Netherlands). CT images were acquired with 512 × 512 pixels at a 1-mm slice thickness.

The target volume of this study was the planning target volume (PTV). The clinical target volume (CTV) and OARs were defined by a single oncologist based on T1-weighted and T2 MR images. The OAR was selectively determined as the spinal cord or cauda equina, according to the tumor location. Normal organs, except the spinal cord and cauda equina, were not analyzed as OARs in this study. PTV and planning organ-at-risk volume (PRV) were generated by adding an isotropic margin of 1 mm from the CTV and OAR, respectively. For dosimetric evaluation and plan optimization, a 1.5-cm ring structure surrounding the PTV (Ring1.5 cm) was created. The PRV overlap inside the PTV was excluded from the PTV to spare more normal tissues, including the spinal cord and cauda equina.

Treatment planning

Every VMAT plan was generated using 10 MV flattening filter-free photon beams from TrueBeam STx with a high-definition 120™ MLC (Varian Medical Systems, Palo Alto, CA, USA). Each VMAT plan consisted of two full arcs with collimator angles of 350° and 273°. All VMATPO were optimized with the PO algorithm of the Eclipse TPS (version 13.7, Varian Medical Systems, Palo Alto, CA, USA) using a fixed 2.5-mm voxel resolution. Additionally, the jaw-tracking option was employed to minimize the leakage dose to the normal tissues. The prescription dose of the PTV was 18 Gy in a single fraction of the spine SABR. During optimization, planning constraints of the Radiation Therapy Oncology Group (RTOG) 0631 study were followed to spare normal organs and avoid complications. Table 1 lists the planning constraints of the target volume, and OARs for the spine SABR. Conservatively, these constraints are applied to the corresponding PRVs. Automatic normal tissue optimization (NTO) with a priority of 300 was used. To improve the dosimetric plan quality, all VMATPO were reoptimized using the current dose distribution as a reference. Dose distributions were calculated using the Acuros XB advanced dose calculation algorithm (version 13.7, Varian Medical Systems, Palo Alto, CA, USA) with a calculation grid of 2 mm. Each plan was normalized such that at least 80% of the PTV received a prescribed dose.

Table 1 Planning constraints of planning target volume, normal organs and planning organ at risk volumes for spine stereotactic ablative radiotherapy plans

For comparison, all VMATPRO were optimized with the PRO algorithm of Eclipse TPS (version 13.7) using the identical beam geometry and planning protocols. To investigate the variation due to the optimization algorithms separately, the same planning constraints, objectives, automatic NTO and priorities for the target volume and normal tissues were used for both VMATPRO and VMATPO.

Evaluation of treatment plan

The dose-volumetric (DV) parameters calculated from each plan were analyzed to evaluate the dosimetric quality with respect to the target coverage and dose received by normal organs. For the PTV, the evaluated DV parameters were the maximum dose, minimum dose, mean dose, and the dose received at least 98% volume of the target volume (D98%), D90%, D5%, and D2% were calculated. The conformity index suggested by Paddick et al. (CIpaddick) and the homogeneity index (HI) were calculated as follows [21,22,23]:

$${CI}_{paddick}=\frac{{TV}_{prescription dose}}{TV}\times \frac{{TV}_{prescription dose}}{{V}_{prescription dose}}$$
(1)
$$\text{H}\text{I}= \frac{{D}_{2\%}-{D}_{98\%}}{mean dose}$$
(2)

where TVprescription dose is the target volume covered by the prescription dose, TV is the target volume, and Vprescription dose is the volume of the prescription dose.

For the spinal cord and the corresponding PRVs, the evaluated DV parameters were the maximum dose, mean dose, D1.2 cc, D0.35 cc, and D0.035 cc. For the cauda equina and the corresponding PRVs, the maximum dose, mean dose, D1.5 cc, D0.5 cc, D0.1 cc, and D0.035 cc were evaluated as DV parameters. For the Ring1.5 cm, the volumes receiving at least 105% of the ring structure (V105%), V110%, and V115% were calculated from each type of plan.

To assess treatment efficiency and deliverability, the total number of MUs and the modulation complexity score for the VMAT (MCSv) were compared. The MCSv proposed by Masi et al. can evaluate the complexity of the MLC movement and beam aperture shape of the VMAT plans [24]. The value of MCSv decreased as the modulation complexity increased. This metric for each plan was calculated using in-house software (MATLAB R2021a, MathWorks, Natick, MA, USA).

Based on the Shapiro-Wilk test for the normality of the two corresponding datasets, a paired t-test or Wilcoxon signed rank test was used for pairwise comparisons of the DV parameters, total MUs, and MCSv between the PO and PRO algorithms. To investigate the correlations of OAR sparing to the level of modulations, we utilized the differences between the two algorithms (PO – PRO, denoted as Δ) in the DV parameters for normal tissues, total MUs, and MCSv. With these data, correlation coefficients and corresponding p-values were obtained by conducting Pearson’s and Spearman’s correlation tests for parametric and non-parametric data, respectively, and p-values were considered statistically significant at p < 0.05. All analyses were performed using the PRISM statistical program (version 8.4.3, GraphPad Software Inc., San Diego, CA, USA).

Results

Dose-volumetric (DV) parameters

Table 2 summarizes the average DV parameters of both VMATPRO and VMATPO for the cervical and thoracic spine cases. For the PTVs, the differences in all the DV parameters analyzed in this study between VMATPRO and VMATPO were statistically significant (p < 0.05), except for D98% and minimum dose (p = 0.167 and 0.141, respectively). The values of D5%, D2%, maximum dose, and mean dose were lower for VMATPRO than for VMATPO while the values of D90% were slightly higher for VMATPRO than for VMATPO. Target conformity and dose homogeneity in the PTVs of VMATPRO were better than those of VMATPO with statistical significance (0.90 vs. 0.82 with p < 0.0001 for CIpaddick and 0.32 vs. 0.35 with p < 0.001 for HI). The overall quality of the DV parameters of the PTVs was superior in VMATPRO than those in VMATPO.

Table 2 Average dose-volumetric parameters of the planning target volume, spinal cord, planning organ at risk volume of spinal cord, and 1.5-cm ring structure surrounding PTV for cervical and thoracic spine stereotactic ablative radiotherapy plans

For the spinal cords and corresponding PRVs, all of the DV parameters for VMATPRO were markedly lower than those for VMATPO, with statistical significance (all p < 0.0001). Among them, the difference in the maximum dose to the spinal cord between VMATPRO and VMATPO was remarkable (9.04 Gy vs. 11.08 Gy with p < 0.0001). For Ring1.5 cm, no significant difference in V115% for VMATPRO and VMATPO was observed. The values of V105% and V110% for VMATPRO were much smaller than those for VMATPO, with the differences being statistically significant (0.44 cm3vs. 2.66 cm3 with p < 0.001 for V105%, and 0.02 cm3vs. 0.63 cm3 with p = 0.039 for V110%).

Table 3 summarizes the average DV parameters of both VMATPRO and VMATPO for the lumbar spine cases. For the PTVs, all of the DV parameters showed significant differences between VMATPRO and VMATPO, except for the minimum dose (p = 0.207). Similar to the DV parameters of the PTVs for cervical and thoracic spine cases, the values of D5%, D2%, maximum dose, and mean dose were lower in VMATPRO than in VMATPO. In contrast, the values of D98% and D90% were slightly higher for VMATPRO than for VMATPO, demonstrating that VMATPRO exhibited coverage and uniformity of the dose to the PTV. In the same vein, the target conformity and dose homogeneity in the PTVs of VMATPRO were better than those of VMATPO, with statistical significance (0.92 vs. 0.86 with p < 0.0001 for CIpaddick and 0.26 vs. 0.29 with p < 0.0001 for HI).

Table 3 Average dose-volumetric parameters of the planning target volume, cauda equina, planning organ at risk volume of cauda equina, and 1.5-cm ring structure surrounding PTV for lumbar spine stereotactic ablative radiotherapy plans

For the cauda equina and the corresponding PRVs, all of the DV parameters for VMATPRO were considerably smaller than those for VMATPO, showing statistically significant differences (all p < 0.0001). In particular, the difference in D0.035 cc of the cauda equina between VMATPRO and VMATPO was remarkable (11.19 Gy vs. 12.40 Gy with p < 0.0001). For Ring1.5 cm, V115% showed no significant differences between VMATPRO and VMATPO. Similar to the DV parameters of the PTVs for the cervical and thoracic spine cases, the values of V105%, and V110% for VMATPRO were much smaller than those for VMATPO, with the differences being statistically significant (1.03 cm3vs. 3.20 cm3 with p < 0.0001 for V105%, and 0.09 cm3vs. 0.46 cm3 with p = 0.008 for V110%).

Overall, the use of the PRO algorithm for generating VMAT plans could provide better target coverage and sparing of normal tissues surrounding the target volumes for spine SABR. For the dosimetric evaluation, the dose distributions of VMATPRO and VMATPO from a representative patient are shown in Fig. 1. The dose-volume histograms for this patient are shown in Fig. 2.

Fig. 1
figure 1

Representative dose distributions of spine stereotactic ablative radiotherapy cases (patient #29 and #23) for thoracic (T) and lumbar (L) spines, respectively, are shown. Dose distributions of volumetric modulated arc therapy plans generated by a progressive resolution optimizer (VMARPRO) (a) and by a photon optimizer (VMATPO) (b) for patient #29 are shown. For patient #23, dose distributions of VMATPRO (c) and VMATPO (d) are also shown. Doses are depicted by color wash with 7 Gy (the lowest dose) in blue, and 20 Gy (maximum dose) in red. The lowest dose, 7 Gy, was chosen to represent the minimum doses inducing the radiation myelopathy

Fig. 2
figure 2

Representative dose-volume histograms of spine stereotactic ablative radiotherapy (SABR) cases (patient #29 and #23) for thoracic (T) spine (a) and lumbar (L) spine (b), respectively, are shown. A progressive resolution optimizer (PRO), and photon optimizer (PO) are plotted with the solid and dashed lines, respectively, for planning target volume (PTV), spinal cord (SC), the corresponding planning organ-at-risk volume (SC PRV), cauda equine (CE), the corresponding PRV (CE PRV), and 1.5-cm ring structure surrounding PTV (Ring1.5 cm)

Total MU and MCSv

The average total MUs and MCSv values are listed in Table 4. In the cervical and thoracic spine SABR cases, the PRO algorithm generated more complex VMAT plans with significantly higher total MUs than the PO algorithm, showing statistical significance (6020.4 vs. 4850.1 with p < 0.0001 for total MUs and 0.389 vs. 0.495 with p < 0.0001 for MCSv). Similarly, the lumbar spine SABR showed higher total MUs and modulation for VMATPRO than VMATPO (6267.8 vs. 5038.2 with p < 0.0001 for total MUs and 0.425 vs. 0.528 with p < 0.0001 for MCSv).

Table 4 Average total monitor units and modulation complexity score for volumetric modulated arc therapy for cervical and thoracic, and lumbar spine stereotactic ablative radiotherapy plans

Correlation of DV parameters with total MU and MCSv

The values of the correlation coefficient (r) and corresponding p-values of Δ in the DV parameters with total MUs and MCSv for cervical and thoracic spine SABR are shown in Table 5. In general, Δ in the DV parameters of the spinal cord and spinal cord PRV showed a strong correlation with Δ in the total MUs and MCSv, except for the Ring1.5 cm (with p < 0.05). The values of r of ΔD1.2 cc and Δmean dose of spinal cord, and ΔD0.035 cc and Δmean dose of spinal cord PRV for ΔMU and ΔMCSv were larger than 0.69, and 0.79, respectively, with statistical significance (p < 0.001).

Table 5 Correlation coefficients (r) with corresponding p-values of Pearson’s or Spearman’s correlation test of dose-volumetric parameters of organ-at-risk volumes to modulation complexity score for volumetric modulated radiation therapy and total monitor units for cervical and thoracic spine stereotactic ablative radiotherapy plans

The values of r and the corresponding p-values of Δ in the DV parameters with total MUs and MCSv for lumbar spine SABR are shown in Table 6. Overall, Δ in the DV parameters of the spinal cord and spinal cord PRV showed a moderate correlation with Δ in the total MUs and MCSv, except for the Δmaximum dose of the cauda equina, ΔD0.1 cc, ΔD0.035 cc, and Δmaximum dose of the cauda equina PRV ( p < 0.05). For the Δmean dose of the cauda equina, the maximum values of r with p values less than 0.0001 were observed (-0.802 for ΔMU and 0.834 for ΔMCSv).

Table 6 Correlation coefficients (r) with corresponding p-values of Pearson’s and Spearman’s correlation test of dose-volumetric parameters of organ-at-risk volumes to modulation complexity score for volumetric modulated radiation therapy and total monitor units for lumbar stereotactic ablative radiotherapy plans

Discussion

In this study, we evaluated the performance of the PRO and PO algorithms for generating spine SABR VMAT plans by comparing the DV parameters of the target volume and surrounding normal tissues, total MU, and MCSv. To date, this study is the first attempt to assess the plan quality of VMATPRO and VMATPO in patients with cervical, thoracic, and lumbar spinal tumors. When comparing the DV parameters of the target volume and surrounding normal tissues, VMATPRO achieved better PTV coverage and dose uniformity while reducing the dose to the spinal cord or cauda equina and Ring1.5 cm than VMATPO. However, for VMATPRO, improvements in plan dosimetric quality can lead to increases in overall plan complexity and total MUs, which can compromise treatment deliverability and efficiency, respectively.

Similar studies have investigated the optimization algorithms in terms of dosimetric quality for various SABR treatment sites, such as the lungs and brain [17,18,19]. Visak et al. investigated the dosimetric quality of VMATPRO and VMATPO in 12 lung SABR patients with a single dose of 30 Gy [18]. They demonstrated that the PRO algorithm provided higher MUs and higher modulation of lung SABR VMAT plans, while the dose to normal tissues was reduced compared with the PO algorithm. They also reported that the PO algorithm increased the intermediate-dose spillage, which can result from more exposure to normal tissues [18]. In contrast, some institutions demonstrated that the plan quality between both algorithms was comparable with no statistical significance, although VMATPRO increased the total MUs and plan complexity [17, 19]. For the prostate, head and neck, and brain treatment sites, which do not involve SABR VMAT plans, there was an increase in the total MUs and the level of modulation when the PO algorithm was used, showing better OAR sparing and an opposite result to the SABR VMAT plans [16, 20]. Thus, the efficacy of the optimization algorithms may vary depending on the radiotherapy regimen or treatment site. Therefore, it is necessary to analyze the plan quality for each condition.

The PRO algorithm, which utilizes a point-cloud model, can have a high number of calculation points (1) inside small or narrow structures, such as lenses, optic nerves, and spinal cords, or (2) around the edge of irregular structures, such as vertebral bodies and head and neck nodes [25]. In addition, the grid size for the structure can be adjusted as much as the user wants, resulting in an increase in the calculation points inside the structure. Because this facilitates more degrees of freedom for the calculation grid size, a sophisticated modulation scheme of VMAT plans is possible using the PRO algorithm [16]. With these characteristics, the PRO algorithm can generate many small and irregular MLC openings compared with the PO algorithm. In contrast, the PO algorithm uses only one fixed grid size with a single matrix over the CT images during optimization, and the degrees of freedom for the calculation grid size are relatively small compared with the PRO algorithm. The matrix resolution of PO algorithm can be selected from three options (Fine, Normal, and Fast) of 1.25, 2.5, and 5 mm, respectively. This study used the Normal resolution rather than the Fine resolution because it required huge amount of computer memory and long computation time. There were no studies evaluating the effect of the matrix resolution of PO algorithm on the optimization performance. Empirically, changes in the matrix resolution below 2.5 mm did not show the dosimetric differences when a few spine cases were tested for our study. The PO algorithm tends to significantly remove small openings when compared with the PRO algorithm [17]. The MLC openings for randomly selected control points between VMATPRO and VMATPO for a representative spine SABR patient are shown in Fig. 3. It was observed that MLC shapes defined by the PRO algorithm were smaller and more irregular than those defined by the PO algorithm, and were associated with sparing critical normal organs during optimization. Spine SABR has the characteristic of having a long and narrow OAR including the spinal cord or cauda equina that must be protected within an irregular PTV of the vertebral body. Limiting the number of calculation points per volume leads to a potential loss of information that must be considered during optimization. To effectively reduce the dose to the spinal cord or cauda equina, which are widely recognized as critical organs, during optimization, the use of the PRO algorithm would be more advantageous for spine SABR VMAT plans because of the ability to generate small or irregular MLC shapes, and the greater degrees of freedom for the calculation grid size. For the dosimetric evaluation, the dose distributions in VMATPRO and VMATPO for spine SABR are shown in Fig. 1. A noticeable dose reduction in the spinal cord or cauda equina for VMATPRO was achieved compared with VMATPO that had good PTV coverage.

Fig. 3
figure 3

Multi-leaf collimator openings for randomly selected control points between volumetric modulated arc therapy plans generated by a progressive resolution optimizer (VMATPRO) (a) and by a photon optimizer (VMATPO) (b) for a representative spine stereotactic ablative radiotherapy patient

Until now, the latest released version of Varian Eclipse is 16.2. Varian has announced that PRO algorithm is no longer supported from version 16.0 onwards and has no improved functions up to the version 16.0. On the other hand, PO algorithm has been continuously improving its features until 16.2. Among them, the most representative feature to affect the optimization performance is the aperture size controller (ASC) released in version 15.5. With this function, the users are allowed to control the field aperture shape, which results in increasing the field size and then decreasing the complexity of the MLC apertures. The users can adjust the complexity of the plan generated PO algorithm through the ASC function, which may lead to different results from the version of the plan used in our study. However, even before ASC was developed, it was demonstrated that PO algorithm (ver. 13.7) had a tendency to generate simpler field apertures than PRO algorithm shown in Fig. 3. For this reason, it is likely to show similar results for the dosimetric comparison between PRO and PO algorithms, regardless of version of algorithm. Nevertheless, This will be investigated in future studies because no planning study of VMAT for spine SABR generated using different versions of PO algorithms has been performed.

To improve the dosimetric plan quality, high modulation, implying complex MLC movements and the usage of small or irregular MLC apertures, is required; however, this leads to an increase in the number of total MUs and a decrease in plan delivery accuracy [16, 26]. Liu et al. compared PRO and PO algorithms in terms of plan quality and correlations between gamma passing rates and plan complexities for both lung SABR and brain SRS [17]. The criteria for the gamma analysis were 3%/3 mm and 2%/2 mm for lung SABR and 5%/1 mm and 3%/1 mm for brain SRS, with 10% as the threshold value. They reported less agreement between planned and delivered dose distributions when VMATPRO had higher MLC variability and total MUs. Although the overall gamma passing rates with all gamma criteria for VMATPRO decreased compared with those for VMATPO, the average gamma passing rates for lung SABR and brain SRS were above 90% and 95% under the criteria of 2%/2 mm and 3%/1 mm and 3%/3 mm and 5%/1 mm, respectively, and VMATPRO was considered clinically acceptable [17]. In this regard, our institution acquired the gamma passing rates of portal dosimetry with gamma criteria of 2%/1 mm, and all VMATPRO and VMATPO (> 90%) were found to be clinically acceptable. Additionally, our previous study investigated the correlation between gamma passing rates and the modulation degree of VMAT plans [27]. We utilized identical TrueBeam STx with a high-definition 120™ MLC and then generated 100 VMAT plans with various tumor sites, including the lung, spine, liver, brain, and head and neck, using the PRO algorithm. Measurements of the dose distributions for each VMAT plan were acquired using MapCHECK2™ and ArcCHECK™ (Sun Nuclear Corporation, Melbourne, FL, USA). As a result, the average gamma passing rates for all criteria were above 90%, which is regarded as clinically acceptable. It was found that there was less correlation between gamma passing rates with all criteria and MCSv, with no statistical significance, except for the correlation of the 3%/3 mm criterion with ArcCHECK™ (r = 0.210, p-value = 0.036) [27]. Thus, we can conclude that TrueBeam STx has a guaranteed performance with a high degree of agreement between the planned and actual delivered doses, regardless of plan complexity. For the TrueBeam STx used in this study, the modulation degree of the VMAT plans according to the optimization algorithm could be considered less important. Nevertheless, careful evaluation of its deliverability as well as that of other treatment machines is needed for the clinical implementation of the PRO algorithm.

Radiation myelopathy is a rare but catastrophic complication of radiation exposure to the spinal cord or cauda equine [1,2,3]. The RTOG 0631 guidelines recommend dose constraints to the spinal cord (D1.2 cc < 7 Gy, D0.35 cc < 10 Gy, and D0.035 cc < 14 Gy) and cauda equina (D5 cc < 14 Gy, and D0.035 cc < 16 Gy) for spine SABR [28]. However, according to the retrospective study by Sahgal et al., the maximum dose of the spinal cord in a single fraction was estimated, ranging from 9.20 to 12.40 Gy which was associated with a 1–5% risk of radiation myelopathy [12, 29]. For the cervical and thoracic spine SABR in our study, the maximum dose to the spinal cord for VMATPRO (9.04 Gy) was approximately 2 Gy less than that for VMATPO (11.08 Gy), resulting in a 2% reduction in the risk of radiation myelopathy. The maximum dose of spinal cord PRV for VMATPO (13.83 Gy) exceeded 12.40 Gy while that for VMATPRO (12.25 Gy) did not. Since radiation myelopathy can lead to death, it is important to reduce the risk of this complication by sparing the spinal cord or cauda equina as much as possible. Therefore, patients treated with spine SABR may benefit from VMATPRO.

Conclusions

The use of VMATPRO resulted in improved coverage and uniformity of dose to the PTV, as well as OARs sparing, compared with that of VMATPO for cervical, thoracic, and lumbar spine SABR. Better dosimetric plan quality generated by the PRO algorithm was observed to result in higher total MUs and plan complexity. Therefore, careful evaluation of its deliverability should be performed with caution during the routine use of the PRO algorithm.

Data Availability

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request and have been provided to the journal as supplementary material.

Abbreviations

SABR:

Stereotactic ablative radiotherapy

VMAT:

Volumetric modulated arc therapy

MLC:

Multi-leaf collimator

OAR:

Organ at risk

IMRT:

Intensity modulated radiotherapy

DVH:

Dose-volume histogram

TPS:

Treatment planning system

PO:

Photon optimizer

DVO:

Dose-volume optimizer

PRO:

Progressvie resolution optimizer

MU:

Monitor unit

SRS:

Stereotatic radiosurgery

VMATPRO :

PRO-generated VMAT plan

VMATPO :

PO-generated VMAT plan

CT:

Computed tomography

PTV:

Planning target volume

CTV:

Clinical target volume

PRV:

Planning organ-at-risk volume

Ring1.5 cm :

1.5-cm ring structure surrounding the PTV

RTOG:

Radiation Therapy Oncology Group

NTO:

Normal tissue optimization

MCSv :

Modulation complexity score for the VMAT

r :

Correlation coefficient

References

  1. Wong DA, Fornasier VL, MacNab I. Spinal metastases: the obvious, the occult, and the impostors. Spine (Phila Pa 1976). 1990;15(1):1–4.

    Article  CAS  PubMed  Google Scholar 

  2. Ecker RD, Endo T, Wetjen NM, Krauss WE. Diagnosis and treatment of vertebral column metastases. Mayo Clin Proc. 2005;80(9):1177-86.

  3. Weilbaecher KN, Guise TA, McCauley LK. Cancer to bone: a fatal attraction. Nat Rev Cancer. 2011;11(6):411–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Kim KH, Lee H, Sohn MJ, Mun CW. In-house developed surface-guided repositioning and monitoring system to complement in-room patient positioning system for spine radiosurgery. Prog Med Phys. 2021;32(2):40–9.

    Article  Google Scholar 

  5. Zaikova O, Fossa SD, Bruland OS, Giercksky KE, Sandstad B, Skjeldal S. Radiotherapy or surgery for spine metastases? Acta Orthop. 2011;82(3):365–71.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Zhuang H, Zhuang H, Lang N, Liu J. Precision Stereotactic Radiotherapy for spinal tumors: mechanism, efficacy, and issues. Front Oncol. 2020;10:826.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Marta GN, de Arruda FF, Miranda FA, Silva ARNS, Neves-Junior WFP, Mancini A, et al. Stereotactic ablative radiation therapy for spinal metastases: experience at a single brazilian institution. Rep Pract Oncol Radiother. 2021;26(5):756–63.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Patel PR, Kirkpatrick J, Salama JK, Nelson J, Broadwater G, Allen K, et al. Stereotactic ablative body radiotherapy (SABR) for effective palliation of metastases: factors affecting local control. J Radiosurg SBRT. 2014;3(2):123–9.

    PubMed  PubMed Central  Google Scholar 

  9. Sánchez-Iglesias ÁL, Morillo-Macías V, Santafé-Jiménez A, Ferrer-Albiach C. Bone-only oligometastatic prostate cancer: can SABR improve outcomes? A single-center experience. Radiat Oncol J. 2022 Sep;40(3):192–9.

  10. Kim TH, Chang JS. Abscopal effect after palliative five-fraction radiation therapy on bone and lymph node metastases from luminal B breast cancer: a case report and clinical implications for palliative radiation therapy. Radiat Oncol J. 2021 Jun;39(2):139–44.

  11. Ong WL, Wong S, Soliman H, Myrehaug S, Tseng CL, Detsky J et al. Radiation myelopathy following stereotactic body radiation therapy for spine metastases. J Neurooncol. 2022.

  12. Sahgal A, Weinberg V, Ma L, Chang E, Chao S, Muacevic A, et al. Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice. Int J Radiat Oncol Biol Phys. 2013;85(2):341–7.

    Article  PubMed  Google Scholar 

  13. Park JM, Kim JI, Park SY. Prediction of VMAT delivery accuracy with textural features calculated from fluence maps. Radiat Oncol. 2019;14(1):235.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Park JM, Kim K, Chie EK, Choi CH, Ye SJ, Ha SW. RapidArc vs intensity-modulated radiation therapy for hepatocellular carcinoma: a comparative planning study. Br J Radiol. 2012;85(1015):e323–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Lee YK, Bedford JL, McNair HA, Hawkins MA. Comparison of deliverable IMRT and VMAT for spine metastases using a simultaneous integrated boost. Br J Radiol. 2013;86(1022):20120466.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Binny D, Kairn T, Lancaster CM, Trapp JV, Crowe SB. Photon optimizer (PO) vs progressive resolution optimizer (PRO): a conformality- and complexity-based comparison for intensity-modulated arc therapy plans. Med Dosim. 2018;43(3):267–75.

    Article  PubMed  Google Scholar 

  17. Liu H, Sintay B, Pearman K, Shang Q, Hayes L, Maurer J, et al. Comparison of the progressive resolution optimizer and photon optimizer in VMAT optimization for stereotactic treatments. J Appl Clin Med Phys. 2018;19(4):155–62.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Visak J, McGarry RC, Pokhrel D. Clinical evaluation of photon optimizer (PO) MLC algorithm for stereotactic, single-dose of VMAT lung SBRT. Med Dosim. 2020;45(4):321–6.

    Article  PubMed  Google Scholar 

  19. Sanford L, Pokhrel D. Improving treatment efficiency via photon optimizer (PO) MLC algorithm for synchronous single-isocenter/multiple-lesions VMAT lung SBRT. J Appl Clin Med Phys. 2019;20(10):201–7.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Kim YL, Chung JB, Kang SH, Eom KY, Song C, Kim IA, et al. Dosimetric and radiobiological evaluation of dose volume optimizer (DVO) and progressive resolution optimizer (PRO) Algorithm against Photon optimizer on IMRT and VMAT Plan for prostate Cancer. Prog Med Phys. 2018;29(4):106–14.

    Article  Google Scholar 

  21. Ahn BS, Park SY, Park JM, Choi CH, Chun M, Kim JI. Dosimetric effects of sectional adjustments of collimator angles on volumetric modulated arc therapy for irregularly-shaped targets. PLoS ONE. 2017;12(4):e0174924.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Hodapp N. The ICRU Report 83: prescribing, recording and reporting photon-beam intensity-modulated radiation therapy (IMRT). Strahlenther Onkol. 2012;188(1):97–9.

    Article  CAS  PubMed  Google Scholar 

  23. Park JM, Park SY, Ye SJ, Kim JH, Carlson J, Wu HG. New conformity indices based on the calculation of distances between the target volume and the volume of reference isodose. Br J Radiol. 2014;87(1043):20140342.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Masi L, Doro R, Favuzza V, Cipressi S, Livi L. Impact of plan parameters on the dosimetric accuracy of volumetric modulated arc therapy. Med Phys. 2013;40(7):071718.

    Article  PubMed  Google Scholar 

  25. EclipseTM Photon and electron reference guide. In: Alto P, editor. Document ID P1015026-001-A ed. CA, UAS. Varian Medical Systemts Inc.; 2015. p. 343.

  26. Broderick M, Leech M, Coffey M. Direct aperture optimization as a means of reducing the complexity of Intensity Modulated Radiation Therapy plans. Radiat Oncol. 2009;4:8.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Park JM, Kim JI, Park SY. Modulation indices and plan delivery accuracy of volumetric modulated arc therapy. J Appl Clin Med Phys. 2019;20(6):12–22.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Ryu S, Pugh SL, Gerszten PC, Yin FF, Timmerman RD, Hitchcock YJ, et al. RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1–3) spine metastases: phase 2 results. Pract Radiat Oncol. 2014;4(2):76–81.

    Article  PubMed  Google Scholar 

  29. Sahgal A, Chang JH, Ma L, Marks LB, Milano MT, Medin P, et al. Spinal cord dose tolerance to stereotactic body Radiation Therapy. Int J Radiat Oncol Biol Phys. 2021;110(1):124–36.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This work was supported by a VHS Medical Center Research Grant, Republic of Korea (grant number: VHSMC22016).

Author information

Authors and Affiliations

Authors

Contributions

SYP and SS conceived of the study concept, compiled and analyzed data, drafted the manuscript, and participated in all aspects of the study. SS generated radiotherapy plans and processed data. SYP and SS discussed improving the significance of this study. SS oversaw and verified the completion of the study. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Sangjun Son or So-Yeon Park.

Ethics declarations

Ethics approval and consent to participate

Approval for this study was obtained from the Institutional Review Board of Veterans Health Service Medical Center (IRB No. 2020-11-008). Written informed consent was obtained from all patients and parents/legally authorized representative of all minor and deceased patients were obtained. All methods were performed in accordance with the national guideline and institutional regulation.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Son, S., Park, SY. Progressive resolution optimizer (PRO) predominates over photon optimizer (PO) in sparing of spinal cord for spine SABR VMAT plans. BMC Cancer 23, 445 (2023). https://doi.org/10.1186/s12885-023-10925-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12885-023-10925-z

Keywords